Point-of-Care Test Measures Response to Clopidogrel

 

December 30, 2009

The T-Guide diagnostic test assesses patient response to clopidogrel to screen for the 30 percent of patients who do not respond to the anti-platelet drug. The simple, inexpensive, disposable test kit is designed for point-of-care use. It enables nontechnical staff to run the tests in physicians' offices and clinics.

For more information: www.thrombovision.com